QSAM Biosciences Debt to Equity

The latest debt-to-equity ratio for QSAM is 0.01. That is below the Materials sector average of 0.9. Investors often review this figure alongside QSAM Biosciences's historical trend and sector peers before judging valuation or financial health.

Against Materials companies, QSAM currently prints 0.01 for debt-to-equity ratio, while the sector average sits near 0.9. That is roughly 98.8% below the sector mean. Large gaps often invite a closer look at QSAM Biosciences's growth, margins, and balance sheet.

A debt-to-equity ratio of 0.01 for QSAM Biosciences is not 'good' or 'bad' on its own. Compare it with the peer average (0.9) and with QSAM's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting QSAM's debt-to-equity ratio (0.01), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack QSAM Biosciences's debt-to-equity ratio against similar Materials names. You can also browse sector and industry screens on Stockcircle for a broader set of Materials companies and their key multiples and fundamentals.